Literature DB >> 16433682

Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases.

M Bylaite1, H Moussali, I Marciukaitiene, T Ruzicka, M Walz.   

Abstract

Cathepsin (Cat) L is an important lysosomal proteinase involved in a variety of cellular functions including intracellular protein turnover, epidermal homeostasis and hair development. Hurpin (serpinB13) is a cross-class specific serine protease inhibitor of Cat L. We have analysed the expression and localization of Cat L and hurpin in various inflammatory and neoplastic diseases by immunohistochemistry. Whereas Cat L expression in normal skin was below detection limit, immunoreactivity was detected in chronic inflammatory dermatoses. The highest expression of Cat L was found in psoriasis, atopic eczema and squamous cell carcinoma (SCC) samples. Samples of Lupus erythematosus, folliculitis, acne inversa, chronic leg ulcers and pyoderma gangrenosum demonstrated similar but lower expression for Cat L. In malignant cells of SCC, basal cell carcinoma and malignant melanoma, characteristic staining patterns were observed for Cat L, with more abundant expression at the periphery of the tumor. Expanding our previous work, we found that the expression of hurpin was confined mainly to the basal layer in normal skin samples, whereas hurpin was overexpressed and redistributed in diseased skin. The localization of hurpin in dermatoses and neoplasias differed from that in normal skin in that the highest expression was found in the outermost layers of the granular and upper spinous layers. Similarly to Cat L, the highest expression for hurpin was found in psoriasis and SCC. The results presented here summarize for the first time the expression of the protease Cat L and its inhibitor hurpin in a broad spectrum of skin diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433682     DOI: 10.1111/j.1600-0625.2005.00389.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.

Authors:  Mei-Ling Han; Yi-Fan Zhao; Cai-Hong Tan; Ya-Jie Xiong; Wen-Juan Wang; Feng Wu; Yao Fei; Long Wang; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2016-11-14       Impact factor: 6.150

Review 2.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

3.  Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins.

Authors:  Paulina Kulig; Tomasz Kantyka; Brian A Zabel; Magdalena Banas; Agnieszka Chyra; Anna Stefanska; Hua Tu; Samantha J Allen; Tracy M Handel; Andrzej Kozik; Jan Potempa; Eugene C Butcher; Joanna Cichy
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

4.  Autophagic-lysosomal dysregulation downstream of cathepsin B inactivation in human skin fibroblasts exposed to UVA.

Authors:  Sarah D Lamore; Georg T Wondrak
Journal:  Photochem Photobiol Sci       Date:  2011-07-20       Impact factor: 3.982

5.  A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.

Authors:  Yi-Fan Zhao; Mei-Ling Han; Ya-Jie Xiong; Long Wang; Yao Fei; Xiao Shen; Ying Zhu; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

6.  Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.

Authors:  Immanuel Lerner; Eyal Zcharia; Tzahi Neuman; Esther Hermano; Ariel M Rubinstein; Israel Vlodavsky; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2013-10-30       Impact factor: 9.261

7.  The expression of Cathepsin L in oral lichen planus.

Authors:  Athip Kitkhajornkiat; Sorasun Rungsiyanont; Sineepat Talungchit; Pimporn Jirawechwongsakul; Patrayu Taebunpakul
Journal:  J Oral Biol Craniofac Res       Date:  2020-06-16

8.  Immunohistochemical expression of cathepsin L in atopic dermatitis and lichen planus.

Authors:  Zeinab A Ibrahim; Amal A El Ashmawy; Naeim M Abd El-Naby; Hussein M Ghoraba
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

9.  Ultraviolet A Enhances Cathepsin L Expression and Activity via JNK Pathway in Human Dermal Fibroblasts.

Authors:  Qing-Fang Xu; Yue Zheng; Jian Chen; Xin-Ya Xu; Zi-Jian Gong; Yun-Fen Huang; Chun Lu; Howard I Maibach; Wei Lai
Journal:  Chin Med J (Engl)       Date:  2016-12-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.